scispace - formally typeset
D

Deepak Bansal

Researcher at Post Graduate Institute of Medical Education and Research

Publications -  308
Citations -  2736

Deepak Bansal is an academic researcher from Post Graduate Institute of Medical Education and Research. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 264 publications receiving 2061 citations. Previous affiliations of Deepak Bansal include The National Academy of Sciences, India & Max Healthcare.

Papers
More filters
Journal Article

Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study

TL;DR: Blood transfusion requirement fell by >25% in 8 (50%) patients with a decrease of >40% documented in 3 of these, and no perceptible adverse effects were recognized.
Journal ArticleDOI

Imatinib has adverse effect on growth in children with chronic myeloid leukemia.

TL;DR: The aim was to study the effect of imatinib on growth in children with CML and to establish a protocol for future studies of this drug in patients with chronic myeloid leukemia.
Journal ArticleDOI

Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients.

TL;DR: The study re-emphasizes the need for RBC antigen typing before first transfusion and issue of antigen matched blood (at least for Rh and Kell antigen) and early institution of transfusion therapy after diagnosis is another means of decreasing alloimmunization.
Journal ArticleDOI

Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis.

TL;DR: The frontline treatment for chronic myeloid leukemia is tyrosine kinase inhibitor therapy and there is increasing evidence that imatinib results in growth failure in children; etiology is unclear.
Journal ArticleDOI

Survival outcome in childhood ALL: experience from a tertiary care centre in North India.

TL;DR: This study was designed to assess survival data and identify risk factors and found that children with ALL in developing nations have not kept pace with cure rates in developed countries.